Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iguratimod vs Leflunomide with Methotrexate in RA
NCT02275299Phase 4Unknown
- Sponsor
- Simcere Pharmaceutical Group
- Start
- Sep 2013
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of iguratimod in rheumatoid arthritis (RA), sponsored by Simcere Pharmaceutical Group. Status: unknown.
02
Drugs
iguratimod
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02275299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02275299.